Prostaglandin E1 in Outpatients With Intermittent Claudication

Clinical trial NCT01263925 · COMPLETED

Trial details

NCT number: NCT01263925
Sponsor: UCB Pharma
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Stage II Peripheral Arterial Occlusive Disease Intermittent Claudication Fontaine Stage II PAOD

Start date: 2001-04-01
Primary completion: 2011-04-01
Enrollment: 561

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.